Scilex Holding Company Proceeds from Warrant Exercises
Scilex Holding Company (SCLX) reported Proceeds from Warrant Exercises of $20.36 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2026-04-10
- Scilex Holding Company proceeds from warrant exercises for the quarter ending 2025-12-31 was $10.12M.
- Scilex Holding Company proceeds from warrant exercises for the quarter ending 2024-12-31 was $0.00.
- Scilex Holding Company proceeds from warrant exercises for the quarter ending 2024-09-30 was $400.00K.
- Scilex Holding Company proceeds from warrant exercises for fiscal 2025 was $20.36M.
- Scilex Holding Company proceeds from warrant exercises for fiscal 2024 was $0.00.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 9 month as first filed | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $10.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $20.36M 10-K · filed 2026-04-10 | |||
| 2025-09-30 | $10.24M 10-Q · filed 2025-11-14 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $400.00K derived: sum of 2 quarters · filed 2026-04-10 | $0.00 10-K · filed 2026-04-10 | ||
| 2024-09-30 | $400.00K 10-Q · filed 2025-01-17 | $0.00 10-Q · filed 2025-11-14 | $500.00K 10-Q · filed 2025-01-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |